Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 May 1;181(5):1905-9.
doi: 10.1084/jem.181.5.1905.

The target cell nucleus is not required for cell-mediated granzyme- or Fas-based cytotoxicity

Affiliations

The target cell nucleus is not required for cell-mediated granzyme- or Fas-based cytotoxicity

H Nakajima et al. J Exp Med. .

Abstract

The requirement for target cell nuclei in the two apoptotic death pathways used by cytotoxic lymphocytes was tested using model effector systems in which the granzyme and Fas pathways of target damage are isolated. Mast cell tumors expressing granzymes A and B in addition to cytolysin/perforin lysed tumor target cells about 10-fold more efficiently than comparable effector cells without granzymes. Enucleated cytoplast targets derived from these cells were also lysed with a similar 10-fold effect of granzymes. In contrast to cytoplasts, effector granzyme expression did not influence lysis of red cell targets. The Fas pathway was assessed using the selected cytotoxic T lymphocyte hybridoma subline d11S, which lysed target cells expressing Fas but not those lacking Fas. Similarly, cytoplasts derived from Fas+ but not Fas- cells were also readily lysed by these effector cells. Thus, neither the nucleus itself nor the characteristic apoptotic nuclear damage associated with the two major cell death pathways used by cytotoxic lymphocytes are required for cell death per se.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Biochem Biophys Res Commun. 1975 Apr 7;63(3):669-74 - PubMed
    1. Immunity. 1994 Aug;1(5):357-64 - PubMed
    1. J Immunol. 1978 Jul;121(1):186-91 - PubMed
    1. Immunol Rev. 1983;72:97-118 - PubMed
    1. J Exp Med. 1984 Jul 1;160(1):75-93 - PubMed